Search Results - Sanjiv Kaul

Sanjiv Kaul

Sanjiv Kaul is an Indian American physician-scientist and cardiologist. He is the Ernest C. Swigert Chair of Cardiovascular Medicine and Professor of Medicine and Radiology at the Oregon Health and Science University (OHSU), as well as the founder of Vasocardea, a company developing drugs for small vessel disease and an OHSU spin-off. Most of his work on myocardial contrast echocardiography was conducted at the University of Virginia (UVA), while his research on pericytes and GPR39 was carried out at OHSU.

Kaul is most known for his research in cardiovascular imaging and coronary artery disease, focusing on coronary physiology and pathophysiology in animal models and humans, and he holds multiple patents for his work. His publications comprise over 400 papers with a Scopus H-index of 91 and more than 36,000 citations. He has received honors, including being named among the Castle Connolly Top Doctors in America since 2003, and receiving awards, such as the Established Investigator Award from the American Heart Association in 1992, the Outstanding Investigator Award from the American Federation for Clinical Research in 1995, the first Richard Popp Gifted Teacher Award from the American Society of Echocardiography in 2001, the American Heart Association Women in Cardiology Mentoring Award in 2003, the Distinguished Scientist Award from the American College of Cardiology in 2012, and the American Heart Association's James B. Herrick Award in 2015.

Kaul is a member of the American Society for Clinical Investigation, the Association of American Physicians, and the Association of University Cardiologists. Provided by Wikipedia